Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A glance at adenosine receptors: novel target for antitumor therapy.
Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA. Merighi S, et al. Among authors: leung e. Pharmacol Ther. 2003 Oct;100(1):31-48. doi: 10.1016/s0163-7258(03)00084-6. Pharmacol Ther. 2003. PMID: 14550503 Review.
Binding thermodynamics at the human A(3) adenosine receptor.
Merighi S, Varani K, Gessi S, Klotz KN, Leung E, Baraldi PG, Borea PA. Merighi S, et al. Among authors: leung e. Biochem Pharmacol. 2002 Jan 15;63(2):157-61. doi: 10.1016/s0006-2952(01)00825-5. Biochem Pharmacol. 2002. PMID: 11841789
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA. Merighi S, et al. Among authors: leung e. J Biol Chem. 2005 May 20;280(20):19516-26. doi: 10.1074/jbc.M413772200. Epub 2005 Mar 17. J Biol Chem. 2005. PMID: 15774470 Free article.
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
Gessi S, Varani K, Merighi S, Cattabriga E, Pancaldi C, Szabadkai Y, Rizzuto R, Klotz KN, Leung E, Mac Lennan S, Baraldi PG, Borea PA. Gessi S, et al. Among authors: leung e. Mol Pharmacol. 2005 Jun;67(6):2137-47. doi: 10.1124/mol.104.009225. Epub 2005 Mar 23. Mol Pharmacol. 2005. PMID: 15788741
1,324 results